Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Berrettini

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Archives of General Psychiatry|May 1, 1978
Decreased platelet monoamine oxidase activity in chronic schizophrenia, shown with novel substratesW H Berrettini, W Prozialeck, W H Vogel
The Journal of Clinical Psychiatry|June 1, 1982
Phenelzine treatment of depression with chronic diarrheaK J Weiss, H J Schwartz, W H Berrettini
Schizophrenia Bulletin|January 1, 1980
Further studies on the endogenous inhibitor of monoamine oxidase in schizophrenic plasmaW H Vogel, R K Ladman, W H Berrettini
Peptides|May 1, 1986
Neuropeptide Y immunoreactivity in human cerebrospinal fluidW H Berrettini, J I Nurnberger, D A DiMaggio
Cytogenetics and Cell Genetics|July 28, 2001
C18orf2, a novel, highly conserved intronless gene within intron 5 of the GNAL gene on chromosome 18p11J T Vuoristo, W H Berrettini, L Ala-Kokko
Archives of General Psychiatry|December 1, 1989
Electrodermal activity in young adults at genetic risk for affective disorderT P Zahn, J I Nurnberger, W H Berrettini
Journal of Receptor Research|January 1, 1983
Absence of specific binding of several putative neuro-transmitters to human fibroblastsW H Berrettini, N S Nadi, E S Gershon
Psychiatry Research|October 1, 1987
Growth hormone releasing factor in human cerebrospinal fluidW H Berrettini, J I Nurnberger, S Simmons-Alling
Clinical Pharmacology and Therapeutics|December 23, 2011
The genetics of anorexia nervosaT K Clarke, A R D Weiss, W H Berrettini
Neuropsychobiology|January 1, 1988
Cerebrospinal fluid peptide YY immunoreactivity in eating disordersW H Berrettini, W H Kaye, H Gwirtsman, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Archives of General Psychiatry|May 1, 1978
Decreased platelet monoamine oxidase activity in chronic schizophrenia, shown with novel substratesW H Berrettini, W Prozialeck, W H Vogel
The Journal of Clinical Psychiatry|June 1, 1982
Phenelzine treatment of depression with chronic diarrheaK J Weiss, H J Schwartz, W H Berrettini
Schizophrenia Bulletin|January 1, 1980
Further studies on the endogenous inhibitor of monoamine oxidase in schizophrenic plasmaW H Vogel, R K Ladman, W H Berrettini
Peptides|May 1, 1986
Neuropeptide Y immunoreactivity in human cerebrospinal fluidW H Berrettini, J I Nurnberger, D A DiMaggio
Cytogenetics and Cell Genetics|July 28, 2001
C18orf2, a novel, highly conserved intronless gene within intron 5 of the GNAL gene on chromosome 18p11J T Vuoristo, W H Berrettini, L Ala-Kokko
Archives of General Psychiatry|December 1, 1989
Electrodermal activity in young adults at genetic risk for affective disorderT P Zahn, J I Nurnberger, W H Berrettini
Journal of Receptor Research|January 1, 1983
Absence of specific binding of several putative neuro-transmitters to human fibroblastsW H Berrettini, N S Nadi, E S Gershon
Psychiatry Research|October 1, 1987
Growth hormone releasing factor in human cerebrospinal fluidW H Berrettini, J I Nurnberger, S Simmons-Alling
Clinical Pharmacology and Therapeutics|December 23, 2011
The genetics of anorexia nervosaT K Clarke, A R D Weiss, W H Berrettini
Neuropsychobiology|January 1, 1988
Cerebrospinal fluid peptide YY immunoreactivity in eating disordersW H Berrettini, W H Kaye, H Gwirtsman, et al.
Pageof 13